ARCHIVES

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

NCI CTEP-Approved Trials For the Month of June

June 27, 2014

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009